Vaxart, Inc. ( VXRT) - Stock Earnings
VXRT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
VXRT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 55.0 million USD | 104.2 million USD |
| 2026Q1 | 5.2 million USD | 39.2 million USD |
| 2026Q2 | -13.5 million USD | 27.2 million USD |
| 2026Q4 Est. | — | — |
VXRT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -82.5 million USD | 7.4 million USD |
| 2024 | -66.9 million USD | 28.7 million USD |
| 2025 | 16.3 million USD | 237.3 million USD |
| 2026 Est. | — | — |
VXRT
Price: $0.49
Earnings Per Share: 0.17 USD
P/E Ratio: 3.35
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.0 million
Ebitda: -2.9 millionMarket Capitalization: 101.7 million